Citius realigns management: Mazur named CEO; Holubiak becomes Exec. Vice Chairman for commercial launch

Citius Pharmaceuticals, Inc.

Leonard Mazur appointed CEO and Chairman; Myron Holubiak transitions to Executive Vice Chairman, effective May 1, 2022.
Holubiak to lead commercial team for upcoming I/ONTAK (CTCL) launch and Mino-Lok Phase 3 completion.
CFO Jaime Bartushak adds Chief Business Officer role; Michael McGuire joins as VP, Program Leader for Anti-Infectives.
Holubiak enters amended employment agreement with $450K salary, 50% bonus potential, 18-month initial term.
Company files Form 8-K; press release dated April 13, 2022, details the changes.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Jaime Bartushak

Chief Financial Officer and Chief Business Officer

CTXR · Citius Pharmaceuticals, Inc.

Effective: 2022-05-01
Filed: April 13, 2022, 7:59 PM ET

Chief Financial Officer Jaime Bartushak will assume additional responsibilities as Chief Business Officer.

Role change

Myron Holubiak

Executive Vice Chairman

CTXR · Citius Pharmaceuticals, Inc.

Effective: 2022-05-01
Successor: Leonard Mazur
Filed: April 13, 2022, 7:59 PM ET

the Board appointed Myron Holubiak, the current Chief Executive Officer, to the newly created position of Executive Vice Chairman

Role change

Leonard Mazur

Chief Executive Officer and Chairman

CTXR · Citius Pharmaceuticals, Inc.

Effective: 2022-05-01
Filed: April 13, 2022, 7:59 PM ET

Leonard Mazur, Citius co-founder and Executive Chairman, has been named as Chief Executive Officer and Chairman.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jaime Bartushak changed role as Chief Financial Officer and Chief Business Officer at Citius Pharmaceuticals, Inc..

Action: assume additional responsibilities as
Role: Chief Financial Officer and Chief Business Officer

Exact text from the filing

Chief Financial Officer Jaime Bartushak will assume additional responsibilities as Chief Business Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Myron Holubiak was appointed as Executive Vice Chairman at Citius Pharmaceuticals, Inc..

Action: appointed
Role: Executive Vice Chairman

Exact text from the filing

the Board appointed Myron Holubiak, the current Chief Executive Officer, to the newly created position of Executive Vice Chairman

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Leonard Mazur was named as Chief Executive Officer and Chairman at Citius Pharmaceuticals, Inc..

Action: named
Role: Chief Executive Officer and Chairman

Exact text from the filing

Leonard Mazur, Citius co-founder and Executive Chairman, has been named as Chief Executive Officer and Chairman.

View on SEC.gov

Citius Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-019528

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.